Randomized Phase II Trial of Cytosine Arabinoside with and without the CHK1 inhibitor MK-8776 in Relapsed and Refractory Acute Myeloid Leukemia
Source: Leukemia Research - Category: Hematology Authors: Jonathan A. Webster, Raoul Tibes, Larry Morris, Amanda L. Blackford, Mark Litzow, Mrinal Patnaik, Gary L. Rosner, Ivana Gojo, Robert Kinders, Lihua Wang, L. Austin Doyle, Catherine J. Huntoon, Larry M. Karnitz, Scott H. Kaufmann, Judith E. Karp, B. Dougla Tags: Research paper Source Type: research